QIAGEN IPA
Drug repurposing: from large-scale biological data to therapeutics
416 views
Join us for this 60-minute Webinar on Drug repurposing: from large-scale biological data to therapeutics. This one-hour event will show how our platform enables biologists to leverage transcriptomics and literature-curated biological data for in-silico drug repositioning and repurposing.
Through a series of short demonstrations, we will explore:
• A systems biology approach to discover new uses of existing FDA-approved drugs
• Accelerate drug discovery process and generate novel hypotheses from high-quality omics and literature curated data
• Estimate network of genes potentially perturbed by drugs and integrate it with drug and disease gene expression signatures
• Study how targets of interest are expressed across different diseases and tissues
Our system uses millions of curated literature findings in the QIAGEN/ IPA knowledgebase and the OmicSoft digital warehouse. The presentation is intended for both those familiar with Ingenuity Pathway and newcomers interested in learning more.
Related videos
QIAGEN IPA
Somatic variants investigation in critical regulatory pathways
This training will focus on using QIAGEN Ingenuity Pathway analysis (IPA) and...
QIAGEN IPA
Cross-species comparison and validation for drug discovery and biomarker research using QIAGEN...
Some human studies may be unfeasible or unethical, making cross-species...
QIAGEN IPA
Interpreting genetic risk loci from GWAS in the context of key genes and pathways using QIAGEN...
Genome-wide association studies (GWAS) provide insights into the genetic...
QIAGEN IPA
QIAGEN Ingenuity Pathway Analysis (IPA) for grant writing and publications with new features
QIAGEN Ingenuity Pathway Analysis (IPA) represents a robust resource to aid...